Bristol-Myers Squibb’s $14 Billion Acquisition of Karuna

Simpson Thacher & Bartlett is representing Karuna Therapeutics, Inc. in the transaction.Bristol-Myers Squibb Company (“BMS”, NYSE: BMY) announced its acquisition of Karuna Therapeutics, Inc. (“Karuna”) for $330 in…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here